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Safety assessmentThis study describes the analysis of estragole in dry fennel preparations and in infusions prepared from
them and an associated safety assessment. A wide range of estragole levels of 0.15–13.3 mg/g dry fennel
preparation was found. The estragole content in infusions was considerably lower ranging between 0.4
and 133.4 lg/25 mL infusion prepared from 1 g dry material. Infusions prepared from whole fennel fruits
contained about 3-fold less estragole compared to infusions prepared from ﬁne cut fennel material.
Safety assessment was performed using the Margin of Exposure (MOE) approach comparing available
tumour data to the estimated daily estragole intakes from the consumption of 1–3 cups fennel tea. MOEs
obtained for adults generally point at a low priority for risk management, especially when one cup of
fennel tea is used daily during lifetime. MOEs for use of fennel teas by children were generally
<10,000 indicating a priority for risk management. However, limiting such uses to 1–2 weeks, MOEs
might be 3 orders of a magnitude higher and there would be no priority for risk management. These
results indicate a low priority for risk management actions for use of fennel teas especially for short-term
uses proposed for the symptomatic treatment of digestive disorders.
 2014 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
For many years, botanicals have formed part of the regular diet
as fruits or vegetables, wines, tea, food supplements or as ﬂavours
and fragrances added to food. Additionally, numerous botanicals
and botanical preparations have a long history of use as traditional
herbal medicine. An example of such a botanical used to maintain
health or treat symptoms of disease is fennel (Foeniculum vulgare
Mill.). Fennel based teas are traditionally used in many parts of
Europe including France, Germany, Austria, Czech Republic and Po-
land were they are often used for the symptomatic treatment of
digestive disorders alleviating mild spasmodic gastro-intestinalailments and the relief of symptoms during inﬂammations of mu-
cous membranes of the upper respiratory tract (EMA, 2008).
Resulting from these proposed health-promoting effects, and the
natural character of fennel, homemade fennel tea is often used as
a remedy for gastrointestinal complaints in infants and young chil-
dren (Crotteau et al., 2006; Perry et al., 2011). Although fennel
based teas have a long history of use and are valued for their
beneﬁcial effects, fennel may contain active ingredients of concern,
such as the alkenylbenzene estragole (Fig. 1) (EFSA, 2012a).
Estragole was previously indicated to be genotoxic and carcino-
genic (SCF, 2001). In response to these ﬁndings, regulatory actions
were taken within the EU restricting the use of estragole
(Regulation (EC) No. 1334/2008 of the European Parliament and
of the Council, 16 December 2008). The potential risks for human
health related to the use of estragole-containing fennel based teas
to relief gastrointestinal disorders, especially in children, have not
(yet) been thoroughly studied and the European Medicines Agency
(EMA, former EMEA) concluded that ‘‘the use of fennel tea is not
recommended in children under 4 years of age due to the lack of
adequate data’’ (EMA, 2008).
A major issue in the safety assessment of estragole and
estragole-containing food items is how to provide guidance on
the potential risks for human health resulting from the exposure
to (low levels of) food-borne compounds that are genotoxic and
Fig. 1. Structural formula of estragole.
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(EFSA) recently indicated that whenever genotoxic and carcino-
genic compounds are present in a botanical or botanical prepara-
tion of interest, the Margin of Exposure (MOE) approach (EFSA,
2005) can be used to evaluate the potential risk for human health
and the priority for risk management actions (EFSA, 2009b). The
MOE is a dimensionless ratio that is obtained by comparing
exposure levels causing malignant tumours in experimental
animals (e.g. the BMDL10 value, the lower conﬁdence bound of
the benchmark dose that gives 10% extra cancer incidence) with
the estimated daily intake in humans (EFSA, 2005). In a previous
evaluation of the EFSA Scientiﬁc Cooperation (ESCO) working
group, the MOE was applied to the use of estragole-containing
tea prepared from bitter fennel fruits (F. Vulgare Mill. var. vulgare)
(EFSA, 2009a). The exposure to estragole was estimated to equal
1.9–15.8 mg per day corresponding to 33–263 lg estragole/
kg bw/day for a person with a body weight of 60 kg (EFSA,
2009a). This theoretical exposure estimate was based on the
assumption that 4.5–7.5 g of fennel fruits would be used on a daily
basis for the preparation of homemade fennel tea, that fennel fruits
contain 5% essential oil, that the essential oil contains 3.5–12%
estragole and that the extraction efﬁciency of the essential oil into
the infusion is equal to 25–35% (EFSA, 2009a). The ESCO working
group calculated the MOE based on the exposure estimates
obtained and BMDL10 values derived from the incidence of malig-
nant liver tumors in female CD-1 mice exposed to estragole (EFSA,
2009a; Miller et al., 1983). The MOEs thus obtained were found to
be relatively low (i.e. MOEs equal to 34–1000) indicating that the
daily use of homemade fennel tea prepared from bitter fennel
fruits would be of high priority for risk management actions (EFSA,
2009a). Raffo et al. (2011) recently experimentally determined the
estragole content in hot water extracts of commercial fennel teas
providing a reﬁnement of the exposure estimate made by the ESCO
working group. It was demonstrated that the consumption of tea
prepared from sweet fennel (F. vulgare Mill. Var. dulce), available
on the Italian market, that was found to contain the highest estrag-
ole level amongst the preparations tested in that study, would
result in 3–26-fold lower estragole exposures compared to those
estimated by the ESCO working group (Raffo et al., 2011). Based
on these lower exposure levels, Raffo et al. (2011) calculated the
MOEs to range between 870 and 3210 which is thus higher than
the MOEs of 34–1000 calculated by the ESCO working group (Raffo
et al., 2011). However, by being lower than 10,000 these MOE
values still point at a priority for risk management.
In general, the use of different exposure estimates (e.g.
theoretical vs. experimental) may result in different daily intake
levels for the same exposure scenario and thus also might provide
different advice to risk managers on the potential risk to human
health. In fact, limitations in exposure estimates are a major source
of uncertainty in safety assessment. Thus, the use of reﬁned intake
estimates for estragole is required to facilitate an accurate outcome
of the safety assessment of fennel based tea preparations.
However, the concentration of estragole may show considerable
variations depending on the variety, geographical origin, harvest-
ing techniques and processing methods amongst others (Smith
et al., 2002) and high variability of the estragole content in fennel
fruits are reported in literature (Dadalioglu and Evrendilek, 2004;
EFSA, 2012a; Miraldi, 1999; Ruberto et al., 2000). Although thework of Raffo et al. (2011) provided an important reﬁnement of
the exposure estimate of estragole resulting from the use of fennel
tea, exposure estimates were only based on the use of sweet fennel
obtained from the Italian market while in addition to sweet
fennel also bitter fennel is widely used to prepare homemade
fennel based teas. In this respect, a further reﬁnement of exposure
data of estragole resulting from the consumption of homemade
fennel tea including different varieties and origins of fennel teas,
but also the experimental determination of the extraction efﬁ-
ciency of estragole into the infusion could improve the accuracy
of the safety assessment. Hence, the aims of the present study were
(1) to make a chemical analysis of estragole in sweet and bitter
fennel teas consisting of commercial preparations of ﬁne cut fennel
material or whole fruits derived from different geographical
origins, and (2) to perform a safety assessment for estragole result-
ing from drinking fennel tea using the MOE approach, taking into
account the previous work by the ESCO working group (EFSA,
2009a) and reported in literature (Raffo et al., 2011).2. Materials and methods
2.1. Chemicals and materials
A total of 34 fennel tea preparations from different brands were purchased from
the internet, obtained from local shops in the Netherlands, Belgium, Germany and
Italy or provided by the European Herbal Infusion Association. Fennel tea prepara-
tions in the form of teabags, unpackaged fennel consisting of whole fruits or ﬁne cut
fennel material, and instant tea granules were included. 7 Fennel tea preparations
consisted of sweet fennel material and 8 fennel tea preparations consisted of bitter
fennel material. The variety of the remaining samples (n = 18) was not speciﬁed.
Product information as indicated on the label of each product is summarized in
Table 1. Estragole (purity 98%) was supplied by Acros organics (Geel, Belgium).
Acetonitrile (ULC/MS gradient) and methanol (HPLC supra gradient) were acquired
from Sigma Aldrich (Steinheim, Germany). Nanopure water was obtained from a
Barnstead nanopure Type I ultra-pure water system.2.2. Methanolic extracts
To allow quantiﬁcation of the total estragole content in the fennel tea samples
expressed per g dry fennel preparation, methanolic extracts were prepared based
on the method previously described (Gursale et al., 2010; van den Berg et al.,
2011). To correct for the amount of estragole lost in this extraction method, a
recovery study was performed as described by van den Berg et al. (2011). The
average percentage recovery was found to equal 90.6 ± 8.1%. This value was used
to correct the total level of estragole in the selected dry fennel preparations for
sample recovery.2.3. Hot water extracts
In addition to the methanolic extracts, hot water extracts were made to reﬂect
the preparation of homemade fennel tea. Extracts were prepared based on the
method previously described by Raffo et al. (2011) with minor modiﬁcations. In
short, tea extracts were prepared by adding 25 mL freshly boiled water to 1 g of fen-
nel tea material. The mixture of hot water and fennel tea material was incubated for
7 min in a covered beaker and stirred three times with a spoon. After 7 min, all fen-
nel material was removed from the infusion and the extract was cooled down to
room temperature. Aliquots of the hot water extracts were centrifuged at 16,000g
for 5 min and the supernatant was stored at 20 C until ultra performance liquid
chromatography (UPLC)-analysis.2.4. UPLC analysis
Before UPLC analysis, aliquots of the methanolic extract solution were diluted in
acetonitrile (1:10 v/v). Aliquots of the hot water extracts were analysed undiluted.
For quantiﬁcation of estragole, 3.5 ll of each sample was subjected to UPLC analysis
(n = 3) as described previously (van den Berg et al., 2011).2.5. Estimation of daily intakes of estragole resulting from the use of fennel based teas
The exposure estimate of estragole resulting from the use of fennel teas was
based on the estragole content in the hot water extracts as determined in the pres-
ent study (see results) together with the assumption that 1.5–2.5 g fennel would be
used for the preparation of a cup of fennel tea as described by the ESCO working
Table 1
Characteristics of fennel based tea samples used, levels of estragole in dry fennel preparations, in water infusions prepared from the selected fennel samples and extraction
efﬁciencies of estragole into the water infusion.
Sample
No.
Varietya Form Origin Average ± STDEV
(lg estragole/g
dry fennel
preparation)b
Average ± STDEV
(lg estragole/25 mL infusion
extracted from 1 g fennel
material)
Extraction efﬁciency of
estragole into the
infusion (%)Sweet Bitter Unknown Fine cut
material
Whole
fruits
Granules
for instant
tea
1 X X Turkey 654.3 ± 113.6 3.1 ± 0.1 0.5
2 X X Turkey 597.4 ± 19.3 ND ND
3 X X China 929.8 ± 5.9 6.8 ± 0.6 0.7
4 X X China 1218.8 ± 212.5 1.1 ± 0.0 0.1
5 X X Bulgaria 1769.8 ± 83.2 16.8 ± 2.2 0.9
6 X X Bulgaria 1601.6 ± 129.1 2.8 ± 0.4 0.2
7 X X China 603.3 ± 65.4 4.9 ± 0.4 0.8
8 X X China 604.5 ± 34.5 1.5 ± 0.0 0.2
9 X X UK 3833.3 ± 196.6 26.6 ± 4.1 0.7
10 X X Netherlands 478.0 ± 37.4 6.8 ± 1.2 1.4
11 X X Netherlands 163.8 ± 17.1 3.7 ± 0.5 2.3
12 X X Netherlands 958.2 ± 122.3 5.2 ± 3.6 0.5
13 X X Germany 913.7 ± 49.5 3.8 ± 1.9 0.4
14 X X Austria 1686.9 ± 129.1 3.0 ± 0.7 0.2
15 X X Austria 1404.2 ± 87.4 9.3 ± 3.0 0.7
16 X X Germany 1453.1 ± 168.7 4.2 ± 1.6 0.3
17 X X Germany 627.8 ± 69.0 3.5 ± 1.1 0.6
18 X X Belgium 1443.8 ± 65.4 8.8 ± 4.9 0.6
19 X X Belgium 158.8 ± 30.4 3.7 ± 1.5 2.3
20 X X Belgium ND 0.4 ± 0.1 ND
21 X X Italy 2227.8 ± 245.6 15.6 ± 5.4 0.7
22 X X India 150.2 ± 17.0 2.3 ± 0.6 1.5
23 X X India 7867.1 ± 1292.1 29.1 ± 8.4 0.4
24 X X Germany 281.9 ± 21.2 5.8 ± 1.2 2.0
25 X X Germany 914.2 ± 90.5 1.6 ± 0.4 0.2
26 X X Italy ND 2.5 ± 0.7 ND
27 X X X Unknown 791.0 ± 78.6 5.7 ± 0.6 0.7
28 X X Unknown 912.6 ± 31.8 12.8 ± 1.9 1.4
29 X X Unknown 638.6 ± 31.8 7.1 ± 0.4 1.1
30 X X Unknown 1499.0 ± 106.7 15.8 ± 5.2 1.1
31 X X Unknown 2383.5 ± 303.2 33.5 ± 2.2 1.4
32 X X Unknown 387.5 ± 18.1 3.3 ± 0.5 0.9
33 X X Unknown 871.9 ± 144.5 10.7 ± 1.4 1.2
34 X X X Unknown 13,248.7 ± 1390.4 133.4 ± 18.5 1.0
ND: not determined.
a Sweet fennel, Foeniculum Vulgare Mill. Var. dulce; bitter fennel, Foeniculum Vulgare Mill. var. vulgare.
b Values represent the total level of estragole in the fennel samples and was determined with the methanolic extraction method applied and corrected for sample recovery
(see materials and methods section for details).
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sumption of one, two or three cups of fennel based tea assuming a body weight
of 70 kg, the default value for adult body weight recently proposed by EFSA (2012b).
2.6. Calculation of the Margin of Exposure values
MOEs were calculated by comparing the previously calculated BMDL10 values of
3.3–6.5 mg/kg bw/day (van den Berg et al., 2011) for the induction of hepatocellular
carcinomas in female mice derived from the data of Miller et al. (1983), with the
estimated daily intakes of estragole resulting from the use of fennel based teas as
determined in the present study. MOEs were rounded to a single signiﬁcant value.3. Results
3.1. Chemical analysis of estragole in dry fennel preparations and in
fennel based teas
Fig. 2 presents, as an example, part of the UPLC chromatogram
of a methanolic as well as a hot water fennel extract detecting the
presence and level of estragole. Table 1 shows that the total
estragole content in the different dry fennel preparations was
found to vary considerably ranging between 0.15 and 13.3 mg/g
dry fennel preparation. Estragole could not be detected in two
samples because the instant tea granules in those speciﬁc samples
only partially dissolved in methanol. The analysis revealed that thecontent of estragole in the hot water extracts was considerably
lower than the estragole content found in the methanolic extracts
(Fig. 2 and Table 1). In fact, results for the hot water extracts from
1 g of fennel material, also presented in Table 1, revealed that the
level of estragole was relatively low in these water infusions
ranging between 0.4 and 133.4 lg/25 mL infusion (Table 1). In
the hot water extract prepared from sample 2, estragole could even
not be detected (Table 1). Comparing the concentration of estragole
in the hot water extracts to the total concentration of estragole in
the dry fennel preparations revealed an extraction efﬁciency of
estragole from fennel into the infusion equal to 0.1–2.3% (Table 1).
Results obtained also show that the variation in the total estragole
content as determined for the dry fennel preparations could not be
attributed to the type of fennel (i.e. sweet or bitter) or the form (i.e.
ﬁne cut fennel material or whole fennel fruits). In fact, calculating
the average estragole content showed the presence of 1.1 ± 0.4 and
1.3 ± 0.2 mg estragole/g dry weight in preparations of sweet (n = 7)
and bitter (n = 8) fennel material, respectively. In addition, dry
fennel preparations consisting of ﬁne cut fennel material (n = 23)
or whole fennel fruits (n = 7) were found to contain on average
1.3 ± 0.3 and 1.2 ± 0.2 mg estragole/g dry fennel preparation,
respectively. In line with these ﬁndings, in water infusions
prepared from 1 g sweet or bitter fennel material, the average
estragole content was comparable (i.e. 9 ± 4 and 11 ± 4 lg
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estragole content in infusions cannot be attributed to the type of
fennel. However, the average estragole content in infusions
prepared from whole fennel fruits (i.e. 3 ± 1 lg estragole/25 mL
infusion) was found to be about 3-fold lower compared to the aver-
age content of estragole in infusions prepared from ﬁne cut fennel
material (i.e. 10 ± 2 lg estragole/25 mL infusion) demonstrating
that the extraction efﬁciency of whole fennel fruits is lower com-
pared to that of ﬁne cut fennel material.
Interestingly, it was shown that the average estragole content in
water infusions prepared from fennel material (i.e. ﬁne cut fennel
material and whole fennel fruits) for which customary selections
of the respective levels of estragole were done (samples 1–8, aver-
age estragole content of 5 ± 2 lg estragole/25 mL infusion pre-
pared from 1 g dry material) was found to be about 3-fold lower
compared to that of the remaining fennel tea preparations (sam-
ples 9–34, average estragole content of 14 ± 5 lg estragole/25 mL
infusion). In addition, it was even shown that estragole could not
be detected in a water infusion that was prepared from sample
2. These results demonstrate that the use of fennel material con-
taining low levels of estragole can have a marked effect on the
estragole content in fennel teas and thus also on the potential risk
for human health resulting from the use of fennel based teas.3.2. Intake estimates and safety assessment of estragole resulting from
drinking fennel based tea by adults
Using the estragole content in hot water extracts as determined
in the present study, intake estimates up to 4.8 or 14.3 lg
estragole/kg bw/day were obtained for a 70 kg person assuming
the daily consumption of one or three cups of fennel based tea
(Table 2). Table 2 presents MOEs that are equal to 200–70,000
for the use of three cups of fennel based tea on a daily basis (i.e.
4.5–7.5 g fennel material) as used in the safety assessment made
by the ESCO working group. For 10 of the 34 selected fennel prep-
arations MOEs were calculated to be >10,000 when assuming the
use of three cups of fennel based teas as presented in Table 2.Fig. 2. Representative sections of UPLC chromatograms of a methanolic fennel extract
chromatogram. To allow chromatographic analysis, methanolic extracts were diluted in
marked with an asterisk (⁄) were not identiﬁed. Chromatograms were obtained at a waInterestingly, the fennel tea preparations for which MOEs lower
than 10,000 were found all consisted of ﬁne cut fennel material.
Assuming the daily consumption of one cup of fennel based tea
throughout life, MOEs of 10,000 and higher were found for the vast
majority (25 out of 34) of the selected fennel tea preparations (Ta-
ble 2). In general, these fennel preparations consisted of whole fen-
nel fruits or instant tea granules. It should be noted that also when
assuming the daily use of one cup of fennel tea, 8 of the 9 samples
for which MOEs lower than 10,000 were found consisted of ﬁne cut
fennel material and 1 of the 9 samples consisted of a mixture of
ﬁne cut fennel material and whole fennel fruits.3.3. Intake estimates and safety assessment of estragole resulting from
drinking fennel based tea by infants
Infants are the main consumer group of homemade fennel
based tea for symptomatic treatment of mild, spasmodic gastro-
intestinal complaints. Therefore, a separate exposure estimate
and subsequent safety assessment were made for this consumer
group focussing on fennel based preparations that are speciﬁcally
marketed for infants (i.e. sample 17, 18, 20 and 21).
Table 3 shows the exposure estimates for estragole resulting
from the use of homemade fennel based teas that are speciﬁcally
marketed for infants. Exposure estimates were made based on
the estragole content in the fennel preparations as determined in
the present study in hot water extracts together with the amount
of ﬁne cut fennel material present in the tea bag assuming one
cup of fennel based tea would be consumed on a daily basis (sam-
ples 17, 18 and 21). For sample 20, consisting of instant tea gran-
ules, the weight of two whipped off tea spoons (the dose
recommended by the respective manufacturer) was used to esti-
mate the daily estragole intake. Exposure estimates reveal a daily
intake of 0.5–6.5 mg/kg bw/day, 0.4–4.7 mg/kg bw/day, 0.3–3.6 mg/
kg bw/day and 0.2–2.6 mg/kg bw/day for infants of 0–3 months,
3–6 months, 6–12 months and 12–36 months of age, respectively
(Table 3). Comparing the BMDL10 values for estragole with the
exposure estimates obtained, for samples 17, 18 and 21 consisting(A) and a hot water extract (B). The insert presents the reduced scale of the same
acetonitrile (1:10 v/v) whereas hot water extracts were analysed undiluted. Peaks
velength of 225 nm.
Table 2
Daily estragole intake estimates resulting from the use of one, two or three cups of fennel tea and corresponding MOEs.
Sample no. Daily intake of estragole
based on the consumption of one
cup fennel teaa(lg/kg bw/day)
MOEb,c Daily intake of estragole
based on the consumption of two
cupsof fennel teaa (lg/kg bw/day)
MOEb,d Daily intake of estragole
based on the consumption of three
cups of fennel teaa (lg/kg bw/day)
MOEb,e
1 0.1 30,000–70,000 0.1–0.2 20,000–70,000 0.2–0.3 10,000–30,000
2 ND >10,000 ND >10,000 ND >10,000
3 0.1–0.2 20,000–70,000 0.3–0.5 7000–20,000 0.4–0.7 5000–20,000
4 <0.1 >10,000 60.1 >10,000 0.1 30,000–70,000
5 0.4–0.6 6000–20,000 0.7–1.2 3000–9000 1.1–1.8 2000–6000
6 0.1 30,000–70,000 0.1–0.2 20,000–70,000 0.2–0.3 10,000–30,000
7 0.1–0.2 20,000–70,000 0.2–0.4 8000–30,000 0.3–0.5 7000–20,000
8 60.1 >10,000 0.1 30,000–70,000 0.1–0.2 20,000–70,000
9 0.6–0.9 4000–10,000 1.1–1.9 2000–6000 1.7–2.8 1000–4000
10 0.1–0.2 20,000–70,000 0.3–0.5 7000–20,000 0.4–0.7 5000–20,000
11 0.1 30,000–70,000 0.2–0.3 10,000–30,000 0.2–0.4 8000–30,000
12 0.1–0.2 20,000–70,000 0.2–0.4 8000–30,000 0.3–0.6 6000–20,000
13 0.1 30,000–70,000 0.2–0.3 10,000–30,000 0.2–0.4 8000–30,000
14 0.1 30,000–70,000 0.1–0.2 20,000–70,000 0.2–0.3 10,000–30,000
15 0.2–0.3 10,000–30,000 0.4–0.7 5000–20,000 0.6–1.0 3000–10,000
16 0.1–0.2 20,000–70,000 0.2–0.3 10,000–30,000 0.3–0.5 7000–20,000
17 0.1 30,000–70,000 0.2–0.3 10,000–30,000 0.2–0.4 8000–30,000
18 0.2–0.3 10,000–30,000 0.4–0.6 6000–20,000 0.6–0.9 4000–10,000
19 0.1 30,000–70,000 0.2–0.3 10,000–30,000 0.2–0.4 8000–30,000
20 <0.1 >10,000 <0.1 >10,000 <0.1 >10,000
21 0.3–0.6 6000–20,000 0.7–1.1 3000–9000 1.0–1.7 2000–7000
22 <0.1 >10,000 0.1–0.2 20,000–70,000 0.1–0.2 20,000–70,000
23 0.6–1.0 3,000–10,000 1.2–2.1 2000–5000 1.9–3.1 1000–3000
24 0.1–0.2 20,000–70,000 0.2–0.4 8000–30,000 0.4–0.6 6000–20,000
25 <0.1 >10,000 0.1 30,000–70,000 0.1–0.2 20,000–70,000
26 0.1 30,000–70,000 0.1–0.2 20,000–70,000 0.2–0.3 10,000–30,000
27 0.1–0.2 20,000–70,000 0.2–0.4 8000–30,000 0.4–0.6 6000–20,000
28 0.3–0.5 7000–20,000 0.5–0.9 4000–10,000 0.8–1.4 2000–8000
29 0.2–0.3 10,000–30,000 0.3–0.5 7000–20,000 0.5–0.8 4000–10,000
30 0.3–0.6 6000–20,000 0.7–1.1 3000–9000 1.0–1.7 2000–7000
31 0.7–1.2 3000–9000 1.4–2.4 1000–5000 2.2–3.6 900–3000
32 0.1 30,000–70,000 0.1–0.2 20,000–70,000 0.2–0.4 8000–30,000
33 0.2–0.4 8000–30,000 0.5–0.8 4000–10,000 0.7–1.1 3000–9000
34 2.9–4.8 700–2000 5.7–9.5 300–1000 8.6–14.3 200–800
ND: not determined.
a Daily intake estimates of estragole were obtained using the estragole content in water infusions prepared from 1 g fennel material as presented in Table 1, assuming the
use of 1.5–2.5 g fennel material for the preparation of a cup of tea (EFSA, 2009a) and a body weight of 70 kg (EFSA, 2012b).
b MOE = BMDL10 (mg/kg bw/day)/daily intake estragole (mg/kg bw/day).
c MOE assuming a daily intake of one cup of fennel tea.
d MOE assuming a daily intake of two cups of fennel tea.
e MOE assuming a daily intake of three cups of fennel tea.
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10,000 indicating a priority for risk management actions (Table 3).
However, it should be noted that for sample 20 consisting of in-
stant tea granules MOEs of 10,000 and higher were found when
tea prepared from this product would be consumed by infants of
6 months and older.4. Discussion
In the present study, a safety assessment for estragole resulting
from drinking fennel based tea was made using the MOE approach
taking into account the previous work in the ﬁeld by the ESCO
working group (EFSA, 2009a) and reported in literature (Raffo
et al., 2011). The results presented show that the consumption of
fennel teas generally presents a low priority for risk management
actions, especially when one cup of fennel tea is consumed by
adults on a daily basis.
Based on the chemical analysis performed in the present study,
estragole was detected in the selected 34 fennel samples in
quantities equal to 0.15–13.3 mg/g dry fennel preparation. This is
comparable to the value resulting from the assumption made by
the ESCO working group of 5% essential oil containing 3.5–12%
estragole which would give rise to 1.75–6 mg/g fennel material(EFSA, 2009a). Assuming that 4.5–7.5 g fennel material per day
would be used for the preparation of fennel tea as described by
the ESCO working group (EFSA, 2009a) and that the extraction
efﬁciency of the essential oil of fennel is 25–35% (EFSA, 2009a),
the daily estragole intake would amount to 3–499 lg/kg bw/day
for a person with a body weight of 70 kg, which is comparable to
the estimate of 33–263 lg/kg bw/day reported by the ESCO work-
ing group. However, this indirect worst case approach using levels
of estragole in fennel material might represent an overestimation
of the actual risk for human health resulting from the use of fennel
tea. Raffo et al. (2011) indicated that the extraction efﬁciency of
fennel essential oil into the infusion of 25–35% as used by the ESCO
working group (EFSA, 2009a) is relatively high leading to an
overestimation of the estragole content in the infusion. In fact,
Zeller and Rychlik (2006) experimentally determined the
extraction efﬁciency for speciﬁc odorants occurring in fennel
essential oil into an infusion demonstrating an extraction
efﬁciency of 12% for estragole which is 2–3-fold lower than the
extraction efﬁciency of 25–35% used in the theoretical worst case
approach reported by the ESCO working group (EFSA, 2009a).
Therefore, in the present study hot water extracts were used rep-
resenting tea preparation by consumers. Results revealed that the
levels of estragole were indeed found to be remarkably lower in
the hot water extracts compared to the total estragole content in
Table 3
Level of estragole in hot water extracts of fennel based tea preparations speciﬁcally marketed for infants, corresponding daily intake estimates and MOEs.
Sample no. Average ± STDEV (lg estragole/25 mL infusion) Daily intake fennel (g)a Daily Intake estragole (lg/kg bw/day)b MOEc
Infants 0–3 months of age
17 3.5 ± 1.1 1.5 1.1 3000–6000
18 8.8 ± 4.9 1.8 3.3 1000–2000
20 0.4 ± 0.1 6.0 0.5 6000–10,000
21 15.6 ± 5.4 2.0 6.5 500–1000
Infants 3–6 months of age
17 3.5 ± 1.1 1.5 0.8 4000–8000
18 8.8 ± 4.9 1.8 2.3 1000–3000
20 0.4 ± 0.1 6.0 0.4 8000–20,000
21 15.6 ± 5.4 2.0 4.7 700–1000
Infants 6–12 months of age
17 3.5 ± 1.1 1.5 0.6 6000–10,000
18 8.8 ± 4.9 1.8 1.8 2000–4000
20 0.4 ± 0.1 6.0 0.3 10,000–20,000
21 15.6 ± 5.4 2.0 3.6 900–2000
Toddlers 1–3 years of age
17 3.5 ± 1.1 1.5 0.4 8000–20,000
18 8.8 ± 4.9 1.8 1.3 3000–5000
20 0.4 ± 0.1 6.0 0.2 20,000–30,000
21 15.6 ± 5.4 2.0 2.6 1000–3000
a Daily intake of fennel is based on the weight of the respective teabags and granules assuming one cup of homemade fennel tea will be used on a daily basis.
b Daily intake estimates of estragole were obtained assuming a body weight of 4.8 kg, 6.7 kg, 8.8 kg, and 11.9 kg for infants of 0–3 months of age, infants of 3–6 months of
age, infants of 6–12 months of age and toddlers of 1–3 years of age respectively (EFSA, 2012b).
c MOE = BMDL10 (mg/kg bw/day)/daily intake estragole (mg/kg bw/day).
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ciencies obtained were 0.1–2.3% and thus lower compared to the
extraction efﬁciency determined by Zeller and Rychlik (2006). This
difference might be explained by the fact that Zeller and Rychlik
(2006) prepared tea from freshly comminuted fennel fruits (2.5 g
in 150 mL hot water) while in the present study dried ﬁne cut fen-
nel material or intact fennel fruits were used. Raffo et al. (2011)
previously indicated that estragole levels determined in water
infusions prepared from intact fruits were 4–6 times lower
compared to the levels in water infusions prepared from
freshly comminuted fruits explaining the difference in extraction
efﬁciency. Moreover, it is likely that fresh fennel fruits contain
higher levels of volatile constituents including estragole compared
to the packaged fennel materials used in the present study as a
result of graduate losses of volatile constituents in crushed
and/or powdered fennel material upon ageing (EMA, 2008).
In fact, in teabags opened for a period of 30 days a 4–10%
decrease in the level of essential oil was previously reported
(EMA, 2008).
Calculation of the MOEs for the intake of estragole from fennel
tea using the levels of estragole in the hot water extracts as
determined in the present study resulted in MOE values that
are generally above the default of 10,000. In spite of this, for some
-though not all- fennel based teas MOEs are still below 10,000
indicating a potential risk for human health and a priority for risk
management actions. However, it is important to note that while
the daily estragole exposure resulting from the consumption of
tea prepared from 1.5 to 2.5 g fennel material three times a day
(i.e. 4.5–7.5 g fennel/day) might pose a potential risk for human
health, the consumption of tea prepared from 1.5 to 2.5 g fennel
seeds one time a day does not. This is because in the latter situ-
ation MOEs above the default of 10,000 are obtained for the vast
majority of samples, i.e. 25 out of 34 samples. Important to note
is that for water infusions prepared from ﬁne cut fennel material
generally relatively low MOEs were obtained. In contrast, MOEs
for water infusions prepared from whole fennel fruits or instant
tea granules were calculated to be generally higher than 10,000
indicating a low priority for risk management actions. In addition,
the present study revealed that MOEs below 10,000 were ob-tained for infants of 0–3 years of age drinking one cup of fennel
tea prepared from ﬁne cut material on a daily basis indicating a
priority for risk management. However, it should be noted that
for infants of 6 months and older also MOEs above 10,000 were
obtained for one sample consisting of instant tea granules. In fact,
the label of the respective fennel based tea product recommends
to use the product only for infants of 6–36 months of age which,
based on the calculated MOEs of 10,000–30,000, would be a low
risk. However, it must be emphasized that in the present paper
MOEs are calculated assuming lifetime exposure while home-
made fennel based teas are generally only used during periods
of gastrointestinal complaints. For this reason, calculation of the
MOEs using the intake estimates as daily intake estimates might
overestimate the potential risk for human health. However, a gen-
eral framework for taking intermittent and/or short-term instead
of lifetime exposures to genotoxic carcinogens into account in the
safety assessment is currently not in place. Felter et al. (2011) re-
cently proposed a framework for assessing the risk from less-than
lifetime exposures to carcinogens. They proposed to use the prin-
ciple of Haber’s Rule provided that chemical-speciﬁc carcinoge-
nicity data are available and that data support a linear dose–
response relationship (Felter et al., 2011). Haber’s Rule assumes
that the acceptable cumulative lifetime exposure can be averaged
over the duration of short-term exposure, suggesting that higher
daily intakes are acceptable when short-term exposure is consid-
ered (Felter et al., 2011). EMA previously indicated that fennel
based teas should not be used for more than two weeks by adults
and less than one week by children under the age of 12 (EMA,
2007). Applying Haber’s Rule to assess the potential risk for
short-term estragole exposure during a period of one week (chil-
dren) and two weeks (adults) on an estimated life expectancy of
75 years might result in MOE values that are 3 orders of a mag-
nitude higher than those obtained when assuming lifetime
(75 years) daily use of fennel based tea. These results indicate
that there may be no reason for risk management actions, when
consuming three cups of fennel based tea on a daily basis for only
two weeks.
Obviously, the calculation of MOEs is based on BMDL10 data
that are obtained from a long-term carcinogenicity study in which
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However, the presence of a natural botanical matrix might
modulate the bioactivation of estragole thereby lowering the
potential cancer risk. In fact, Alhusainy et al. (2012) previously
demonstrated that methanolic extracts from different herbs and
spices were able to inhibit the sulfotransferase-mediated
bioactivation of estragole. The use of such carcinogenicity data in
safety assessment of fennel based teas might thus overestimate
the actual risk. However, in the study of Alhusainy et al. (2012) it
was shown that among the tested alkenylbenzene-containing
herbs and spices, fennel did not show any effect on the sulfotrans-
ferase enzyme activity. Moreover, it was previously shown
that matrix-derived combination effects may be limited at lower
dose levels which are relevant for the use of botanicals and
preparations made thereof (van den Berg et al., 2013). On the basis
of these ﬁndings it can be concluded that the used BMDL10 values
represent an adequate basis for the safety assessment of fennel
based teas.
As shown in the present study, the level of estragole in water
infusions prepared from fennel can vary considerably depending
on the estragole content present in the fennel material used. In
addition, the estragole content in the water infusion might also
depend on the preparation method used. Raffo et al. (2011) dem-
onstrated that the extent of dilution has only a limited effect on
the level of estragole extracted in the infusion. In contrast,
squeezing the teabag to remove any residual water following
the preparation of a fennel infusion was found to result in a con-
siderable increase in the estragole content and was previously
experimentally determined by Raffo et al. (2011) to equal 15%
and Zeller and Rychlik (2009) even demonstrated an increased
extraction of estragole into the infusion equal to 45% (Zeller
and Rychlik, 2009). In addition, the use of freshly comminuted
fennel fruits was shown to increase the estragole content in the
infusion by 4–6-fold compared to the use of intact fennel fruits
(Raffo et al., 2011). It should be noted that reduction of the
estragole content in fennel and fennel based teas is technically
possible (Pank et al., 2003). This can be done by removing estrag-
ole from instant teas through fractionated distillation (Pank et al.,
2003). Moreover, Zeller and Rychlik (2006) indicated that reduc-
tion of the estragole content in fennel tea would not inﬂuence
the overall ﬂavor of fennel tea. Reducing the estragole content
is thus recommended to lower the potential risk to human health,
if any, resulting from the use of fennel based teas. In fact, the
estragole content of one of the analyzed fennel teas consisting
of instant tea granules that was speciﬁcally marketed for infants
of 6 months and older (i.e. sample 20) was relatively low indicat-
ing that such a technology might have been applied to reduce the
estragole content. However, although fractionated distillation can
markedly reduce the estragole content in instant teas, this proce-
dure cannot be applied to the fennel fruits in their original form
which is the form most commonly used in the preparation of fen-
nel based teas (Pank et al., 2003). Breeding new cultivars without
estragole is not (yet) possible (Pank et al., 2003). Moreover,
breeding new fennel cultivars with reduced estragole levels was
found to result in reduced total essential oil contents including
trans-anethole, which gives the characteristic ﬂavour to fennel
tea, meaning that these cultivars are of lower quality. 8 Of the
34 selected samples were prepared from fennel material obtained
by customary selections of the levels of estragole. The average
estragole content in the water infusions prepared from the
respective fennel tea preparations (samples 1–8) was found to
be about 3-fold lower compared to that of the remaining fennel
teas. Moreover, estragole could even not be detected in fennel
based tea prepared from sample 2. This indicates that the use
of fennel material with relatively low estragole levels can havea marked effect on the estragole intake resulting from the use
of fennel based teas.
In addition to estragole, the EFSA compendium indicates trans-
anethole as a substance of possible concern for human health pres-
ent in F. vulgare Mill. (EFSA, 2012a). For trans-anethole the Joint
FAO/WHO Expert Committee on Food Additives (JECFA) derived a
temporary acceptable daily intake (ADI) of 0–2.0 mg/kg bw (JECFA,
1998), which can be used to deﬁne whether exposure resulting
from proposed uses and use levels will be safe. Zeller and Rychlik
(2006) previously demonstrated that trans-anethole is the most
abundant odorant in fennel fruit and in fennel based tea (i.e.
3600 lg trans-anethole in an infusion extracted from 1 g fennel
material). Based on the level of trans-anethole detected by Zeller
and Rychlik (2006) and assuming the daily consumption of one
cup of fennel tea prepared from 1.5 to 2.5 g fennel material the dai-
ly intake of trans-anethole would equal 77–129 lg/kg bw/day for a
70 kg person. Since this value is well below the ADI it can be con-
cluded that the exposure to trans-anethole resulting from the use
of fennel based tea is not of concern for human health.
Altogether, the present study showed that extraction efﬁcien-
cies of estragole into the infusion were considerably lower than
the 25–35% extraction efﬁciency used in the worst case exposure
assessment performed by the ESCO working group. In general,
extraction efﬁciencies were found to be lower for samples con-
sisting of whole fennel fruits compared to that of samples con-
sisting of ﬁne cut fennel material indicating that exposure
assessments should be done on a case-by case basis taking into
account the physical characteristics of the product of interest. In
fact, estragole levels were 3-fold lower in water infusions pre-
pared from whole fennel fruits compared to that in water infu-
sions prepared from ﬁne cut fennel material. Also the use of
fennel material with relatively low estragole levels obtained by
customary selection to prepare fennel based teas resulted in re-
duced estragole levels of about 3-fold. The results obtained gener-
ally point at a low priority for risk management actions for the
use of fennel teas, especially when consuming one cup of fennel
tea on a daily basis prepared from 1.5 to 2.5 g fennel material.
Moreover, assessing the risk from less-than lifetime exposures
to estragole resulting from the use of fennel based teas during a
period of one to two weeks resulted in MOE values that are 3 or-
ders of a magnitude higher indicating low priorities for risk man-
agement actions. Taken together, these results indicate a low
priority for risk management actions and a low risk for human
health for the use of fennel based teas especially for the short-
term proposed uses of fennel based teas for the symptomatic
treatment of digestive disorders alleviating mild spasmodic gas-
tro-intestinal ailments.Conﬂict of Interest
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